Testosterone as a Biomarker for Quality of Life (QOL) Following Androgen Deprivation Therapy (ADT) and Stereotactic Body Radiotherapy (SBRT)
Sarthak Shah(Roosevelt University), Sean P. Collins(Wayne State University)
Cited by 6
Related Papers
The SGLT2 inhibitor empagliflozin in patients hospitalized for acute heart failure: a multinational randomized trial
|Nature Medicine|2022|889
Epidemiology, Pathophysiology and Contemporary Management of Cardiogenic Shock – A Position Statement from the Heart Failure Association of the European Society of Cardiology
|European Journal of Heart Failure|2020|489
Organ Dysfunction, Injury and Failure in Acute Heart Failure: From Pathophysiology to Diagnosis and Management. A Review on Behalf of the Acute Heart Failure Committee of the Heart Failure Association (HFA) of the European Society of Cardiology (ESC)
|European Journal of Heart Failure|2017|406
Impact of empagliflozin on decongestion in acute heart failure: the EMPULSE trial
|European Heart Journal|2022|213
The impact of early standard therapy on dyspnoea in patients with acute heart failure: the URGENT-dyspnoea study
|European Heart Journal|2009|188